Gastrointestinal cancers often develop silently but knowing risk factors and warning signs can lead to earlier detection and ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Inebilizumab (Uplizna) treatment significantly reduced the risk of flares in patients who had IgG4-related disease (IgG4-RD) ...

As researchers and healthcare professionals seek new ways to tackle chronic diseases, targeted approaches like this one could ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...

Check out our weekly list of new fundraisers from Lend A Hand Up, a nonprofit crowdfunding site supporting families in Cass, ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Biomedical research in liver diseases has traditionally depended on animal models, but ethical concerns and the quest for ...

The National Center for Complementary and Integrative Health states that "research doesn't clearly support using cinnamon for ...

Turmeric and black pepper have a synergistic relationship. Learn how to use them together to increase turmeric’s anti-inflammatory benefits.